Pharmacokinetics and Antihypertensive Effects of Candesartan Cilexetil in Patients Undergoing Haemodialysis: An Open-Label, Single-Centre Study

By Schulz Egbert G.  

Clinical Drug Investigation, Vol. 29, Iss. 11, 2009-11 ,pp. : 713-719

Adis International

Access to resources Recommend Favorite

The addition of alprostadil [lipo-prostaglandin E1] to conventional therapy improves exercise intolerance and lowers pulmonary BP in patients with pulmonary arterial hypertension (PAH)

By  

Inpharma, Vol. 1, Iss. 1504, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Valsartan in Hypertensive Patients on Long-Term Haemodialysis

By Leidig M.F.  

Clinical Drug Investigation, Vol. 21, Iss. 1, 2001-01 ,pp. : 59-66

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Lipid-lowering Effect of Fluvastatin in Hypercholesterolaemic Patients on Maintenance Haemodialysis

By Ichimaru N   Takahara S   Moriyama T   Kondo M   Nonomura N   Tanaka T   Wang J-D   Imai E   Okuyama A   Kondo Y  

The Journal of International Medical Research, Vol. 32, Iss. 1, 2004-01 ,pp. : 45-52

Field House Publishing

Access to resources Recommend Favorite

Citalopram pharmacokinetics in patients with chronic renal failure and the effect of haemodialysis

By Spigset Olav   Hägg Staffan   Stegmayr Bernd   Dahlqvist Rune  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 9-10, 2000-12 ,pp. : 699-703

Springer Publishing Company

Access to resources Recommend Favorite